TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03258736

Intervention type: PROCEDURE
Group type: OTHER
Intervention: inguinal hernia surgery
Description: repair of inguinal hernia

Intervention type: PROCEDURE
Group type: OTHER
Intervention: inguinal hernia surgery
Description: repair of inguinal hernia
Study: NCT01502046

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
Description: Sativex 2.7 mg delta-9-tetrahydrocannabinol/2.5 mg cannabidiol Oromucosal Spray. One spray per day, up to a maximum of 12 sprays per day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, One spray per day, up to a maximum of 12 sprays per day.
Study: NCT01947569

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Biological

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Biological

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological
Study: NCT01517997

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon angioplasty.
Description: Infrapopliteal angioplasty using a paclitaxel coated balloon.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Infrapopliteal Primary Drug Eluting Stenting
Description: Infrapopliteal primary stenting using drug-eluting stent(s)
Study: NCT02693704

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing Aids
Description: The only intervention consists in applying a specific processing on some recorded speech signals, and comparing the performance obtained with such processed samples with ones that have not been processed. The applied processing is a binaural spatialization method that consists in filtering an original audio signal to get a left and right versions (for the two ears). The binaural rendering gives the impression that the speech signal (and thus the speaker) is located in a desired position in the environment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing Aids
Description: The only intervention consists in applying a specific processing on some recorded speech signals, and comparing the performance obtained with such processed samples with ones that have not been processed. The applied processing is a binaural spatialization method that consists in filtering an original audio signal to get a left and right versions (for the two ears). The binaural rendering gives the impression that the speech signal (and thus the speaker) is located in a desired position in the environment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing Aids
Description: The only intervention consists in applying a specific processing on some recorded speech signals, and comparing the performance obtained with such processed samples with ones that have not been processed. The applied processing is a binaural spatialization method that consists in filtering an original audio signal to get a left and right versions (for the two ears). The binaural rendering gives the impression that the speech signal (and thus the speaker) is located in a desired position in the environment.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing Aids
Description: The only intervention consists in applying a specific processing on some recorded speech signals, and comparing the performance obtained with such processed samples with ones that have not been processed. The applied processing is a binaural spatialization method that consists in filtering an original audio signal to get a left and right versions (for the two ears). The binaural rendering gives the impression that the speech signal (and thus the speaker) is located in a desired position in the environment.
Study: NCT00399841

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Precision for Spinal Cord Stimulation
Description: During Trial Implant Period, stimulation from single lead initially turned on at the T7 or T8 level, then crossover. At time of permanent implant, subject chooses which level they want the stimulator turned on.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Precision for Spinal Cord Stimulation
Description: During Trial Implant Period, stimulation from single lead initially turned on at the T7 or T8 level, then crossover. At time of permanent implant, subject chooses which level they want the stimulator turned on.
Study: NCT04685746

Intervention type: BEHAVIORAL
Intervention: Balanced Growth Protocol
Description: Assessment of the Balanced Growth Protocol, consisting of audiovestibular testing, motor and cognitive tasks

Intervention type: BEHAVIORAL
Intervention: Balanced Growth Protocol
Description: Assessment of the Balanced Growth Protocol, consisting of audiovestibular testing, motor and cognitive tasks

Intervention type: BEHAVIORAL
Intervention: Balanced Growth Protocol
Description: Assessment of the Balanced Growth Protocol, consisting of audiovestibular testing, motor and cognitive tasks
Study: NCT02815020

Intervention type: OTHER
Group type: OTHER
Intervention: Boot Camp Translation - community-participatory process
Description: Series of meetings and conference calls with expert presentation on patient self-management support, facilitated discussion, and creation of product to bring to community to improve patient self-management support
Study: NCT03022955

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dark chocolate bar
Description: Dark chocolate bar (70% cocoa solids (\~500kcal, \~50% fat)), 100g / day for 3 days to assess postprandial brain activity and colonic transit by FDG-PET.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dark chocolate mousse
Description: Dark chocolate mousse (150g, \~500kcal, \~50% fat) to assess gastric emptying and oro-caecal transit time by scintigraphy.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: White chocolate bar
Description: White chocolate bar (0% cocoa solids (\~500kcal, 50% fat)), 100g / day for 3 days to assess postprandial brain activity and colonic transit by FDG-PET.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: White chocolate mousse
Description: White chocolate mousse (150g, \~500kcal, \~50% fat) to assess gastric emptying and oro-caecal transit time by scintigraphy.
Study: NCT01487187

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Milking the umbilical cord at birth
Description: Infants in the cord-milked group will be placed at or below the level of the placenta, and about 20 cm of the umbilical cord (or the length of cord that is accessible if less than 20 cm) will be vigorously milked towards the umbilicus three times before clamping the cord

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: immediate umbilical cord clamping
Description: immediate cord clamping without milking as per standard practice
Study: NCT01271504

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib
Description: Phase Ib: Cohort 1; 200 mg E7050 + 400 mg Sorafenib Cohort 2; 300 mg E7050 + 400 mg Sorafenib Cohort 3; 400 mg E7050 + Sorafenib

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib
Description: E7050 given orally at 200, 300 or 400 mg once daily.~Sorafenib given orally, 400 mg twice daily.
Study: NCT03158909

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eyemask and earplugs
Description: Eyemask and earplugs for use during the night, to improve sleep.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Orientation about space and time
Description: Information and orientation about space and time, given every night.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Orientation about space and time
Description: Information and orientation about space and time, given every night.
Study: NCT05281497

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health platform
Description: Each participant was provided with a wearable device (a Heart Rate Smart Wristband, GSH405-B6, Golden Smart Home Technology Corporation). Each participant downloaded an app (WowGoHealth app) to connect with the health management platform (GSH AI health platform). Participants' exercise-related data, including number of steps walked, distance, consumed calories, and heart rate, were collected by the wearable devices. All participants were taught to record a dietary diary (taking photos of meals) using a smartphone application. All collected information was uploaded to the health management platform. For the intervention group, we encouraged exercise including an 18-minutes calisthenics made by the Health Promotion Administration, Ministry of Health and Welfare (https://www.youtube.com/watch?v=r3xJW-b2tZY).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health platform
Description: Each participant was provided with a wearable device (a Heart Rate Smart Wristband, GSH405-B6, Golden Smart Home Technology Corporation). Each participant downloaded an app (WowGoHealth app) to connect with the health management platform (GSH AI health platform). Participants' exercise-related data, including number of steps walked, distance, consumed calories, and heart rate, were collected by the wearable devices. All participants were taught to record a dietary diary (taking photos of meals) using a smartphone application. All collected information was uploaded to the health management platform. For the intervention group, we encouraged exercise including an 18-minutes calisthenics made by the Health Promotion Administration, Ministry of Health and Welfare (https://www.youtube.com/watch?v=r3xJW-b2tZY).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social media
Description: We built a LINE group to inspire the intervention group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: exercise including walk and an 18-minutes calisthenics
Study: NCT04541368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CS1 Targeted CAR T-cells
Description: Each subject receive CS1 Targeted CAR T-cells by intravenous infusion
Study: NCT00777062

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VIVITROL (Naltrexone extended-release injectable suspension)
Description: VIVITROL (Naltrexone extended-release injectable suspension), 380 mg injection at the start of weeks 2 and 6.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injection at the start of weeks 2 and 6.
Study: NCT02946671

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: Mogamulizumab (0.1, 0.3 or 1.0 mg/kg) is administered.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: Mogamulizumab (0.1, 0.3 or 1.0 mg/kg) is administered.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: Mogamulizumab (0.1, 0.3 or 1.0 mg/kg) is administered.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab (3.0 mg/kg) is administered.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab (3.0 mg/kg) is administered.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab (3.0 mg/kg) is administered.
Study: NCT03498469

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standardized reintegration package
Description: Participants assigned to this comparison arm will receive a standardized reintegration package that includes individualized case management support and a reunification cash grant Individualized case management will consist of a caseworker-developed individualized care plan with routine caseworker visits at the household level. Home visitation will begin during the family assessment and preparation stages and continue throughout the 15-month post-reunification follow-up period. For the cash grant, the family of each enrolled child will receive a reunification cash grant in the Ugandan Shilling equivalent of $125, administered in two equal disbursements. It is designed to offset the cost of child care.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced reintegration package
Description: Participants assigned to this arm will receive an enhanced reintegration package that consists of the parenting program, individualized case management, and the reunification grant. will be delivered at the household level by project trained parenting facilitators. The program will consist of approximately 13 bi-weekly sessions, which will be delivered over the course of 7 months. The individualized case management and the reunification grant will be similar to those in the comparison arm.
Study: NCT02811718

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management Group 1
Description: Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management Group 2
Description: Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
Study: NCT01322191

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: A single dose of morphine 0.1 mg/kg infused by syringe pump over 10 minutes; urine and blood sample frozen at -80 degrees Celsius
Study: NCT01446146

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Informed decision making
Description: 40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo session
Description: Participant will complete clinician-administered measures in a 40-minute session.
Study: NCT02503319

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: 2 vials ( =1 gram) of Tranexamic Acid oral administered within 5 minutes from the delivery (third stage after labor)~2 vials (=1 gram ) of Tranexamic Acid administered slow intravenous infusion within 5 minutes from the delivery (third stage after labor)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: 2 vials ( =1 gram) of Tranexamic Acid slow intravenous infusion administered within 5 minutes from the delivery (third stage after labor)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 2 vials (=10 IU/International Unit) of oxytocin administered intramuscularly within 5 minutes from the delivery (third stage after labor)
Study: NCT03658642

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS)
Description: This clinical decision support tool will improve the clinician's ability to identify those with OUD, initiate BUP and refer the patient to ongoing Medication Assisted Treatment (MAT)
Study: NCT04071301

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENA SmartCare Change Indicator
Description: Each participating subject will be provided with a Change Indicator and absorbent products for the duration of the investigation. Nine types of absorbent products will be used to collect real-life measurement data in order to assess the mathematical algorithms involved in the TENA SmartCare Change Indicator. Each participating subject will be allocated to the type(s) that are considered most suitable.~Gateways will be placed in the resident's rooms as well as in common areas, this to enable full measurement registration.
Study: NCT02769442

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Terumo SurFlash Plus catheter

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BD Insyte Autoguard catheter
Study: NCT02214511

Intervention type: BEHAVIORAL
Intervention: emotional facial stimuli
Description: Subjects watch passively dynamic facial emotions obtained by emotionnal faces photos morphing. Their rapid facial reactions are recorded by faciel EMG device as eye movement by occulometric device.

Intervention type: BEHAVIORAL
Intervention: emotional facial stimuli
Description: Subjects watch passively dynamic facial emotions obtained by emotionnal faces photos morphing. Their rapid facial reactions are recorded by faciel EMG device as eye movement by occulometric device.

Intervention type: BEHAVIORAL
Intervention: Cyberball game
Description: Ball tossing computer game to manipulate social inclusion status : rejection or inclusion. Social behavior, social pain and inflammatory modification will be assessed after the game.

Intervention type: BEHAVIORAL
Intervention: Cyberball game
Description: Ball tossing computer game to manipulate social inclusion status : rejection or inclusion. Social behavior, social pain and inflammatory modification will be assessed after the game.
Study: NCT03917745

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eHealth mindfulness intervention
Description: The web-based intervention consists of eight sessions including psycho-education about the mechanisms of stress, coping and relaxation, especially related to pregnancy, practicing mindfulness skills (i.e. mindful breathing, mindful moving, observing and letting-go of thoughts and emotions with a non-judgmental attitude), sharing experiences, and doing home assignments. The sessions have been developed specifically for pregnant women and acknowledge pregnancy-related distress. An online coach will review questions and home assignments of the participants. Women will start the training at 16 weeks gestation.
Study: NCT02932930

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: QLB bloc

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: QLB bloc

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.2% Ropivacaine
Description: 0,2ml/kg of 0,2% ropivacaine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% normal saline
Description: 0,2ml/kg of 0.9% normal saline
Study: NCT06106867

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: External pressure to the palm
Description: During the 5-6 cm, 7-8 cm, and 9-10 cm cervical dilatation stages of the labor process, palm external pressure was applied to the pregnant women in the experimental group.
Study: NCT00662597

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASA404

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Study: NCT04901923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACP-196
Description: Participants will receive ACP-196 oral capsule(s) in all parts.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Participants will receive itraconazole 200 mg capsules BID from Days 4 to 8 with meals and then 200 mg capsule QD on Day 9 under fasting state.
Study: NCT03577847

Intervention type: DIAGNOSTIC_TEST
Intervention: Rural CT scanning
Description: Rural computer tomography for acute stroke
Study: NCT01684189

Intervention type: OTHER
Intervention: Patient registry
Description: Patient registry without study intervention
Study: NCT03768622

Intervention type: PROCEDURE
Intervention: surgery for pertrochanteric femoral fracture
Description: surgical treatment for proximal femoral fracture with intramedullary nail type Gamma® Nail or similar in case of pertrochanteric fractures

Intervention type: PROCEDURE
Intervention: surgery for femoral neck fracture
Description: surgical treatment for proximal femoral fracture with a partial hip arthroplasty in case of femoral neck fractures
Study: NCT02125279

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol
Study: NCT01627262

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesalamine
Description: 3x1000mg mesalamine granules per day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3x1000mg placebo granules per day
Study: NCT00945672

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 10 mg/kg
Description: 10 mg/kg every 90 days (5 total doses)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 7.5 mg/kg
Description: 10 mg/kg loading dose followed by 7.5 mg/kg monthly maintenance dosing (total of 13 doses)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo administered every 90 days or monthly to match experimental treatment arms.
Study: NCT01109134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tirofiban intracoronary bolus-only
Description: administer tirofiban bolus intracoronary during primary percutaneous coronary intervention with no additional maintenance infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tirofiban intravenous bolus plus infusion
Description: administer tirofiban bolus intravenously and maintain infusion for up to 18 hours
Study: NCT01590316

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cerebral NIRS oximetry
Description: Cerebral NIRS oximetry during the first 72 hours of life.
Study: NCT03290391

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapid ART initiation
Description: The infectionist will streamline the approval with the ultimate goal of starting participants on ART while they are still hospitalized at the City Addiction Hospital.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for opioid use disorder
Description: Thirteen months of naltrexone treatment for opioid use disorder (injection at baseline, followed by 4 implants).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strengths-based HIV case management
Description: Strengths-based case management: 10 sessions over 12 months in which a trained case manager (CM) meets individually with patients to motivate them to engage in HIV medical care by supporting the recognition of their own strengths to make positive changes in their lives and ultimately improve their HIV outcomes.
Study: NCT00599742

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Balance training
Description: Physical exercise of balance. The training will last 7 weeks, twice per week, 1 hour per session.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motor training
Description: Motor exercise of power and flexibility. The training will last 7 weeks, twice per week, 1 hour per session.